Animal health requirements for movements to other Member States of germinal products of animals of the families Camelidae and Cervidae
Article 38
Operators shall only move to another Member State germinal products collected from animals of the family Camelidae or Cervidae which: (a) have been born and remained since birth in the Union, or have entered the Union in accordance with the requirements for entry into the Union; (b) have remained in a single establishment of origin for a period of at least 30 days prior to the date of collection of the semen, oocytes or embryos; (c) do not come from an establishment, nor have been in contact with animals from an establishment, situated in a restricted zone established due to the occurrence of a category A disease or of an emerging disease relevant for the species in those kept terrestrial animals; (d) come from an establishment where during a period of at least the preceding 12 months prior to the date of collection of the semen, oocytes or embryos: (i) a surveillance programme to detect infection with Mycobacterium tuberculosis complex ( M. bovis, M. caprae and M. tuberculosis ) has been carried out in accordance with Part 2 or 3 of Annex II to Delegated Regulation (EU) 2020/688; (ii) no animals of the family Camelidae or Cervidae which do not fulfil the requirements referred to in point (i) has been introduced; (iii) in case of suspicion of infection with Mycobacterium tuberculosis complex ( M. bovis, M. caprae and M. tuberculosis ), investigations were carried out and the disease was ruled out; (e) come from an establishment: (i) where infection with Brucella abortus, Brucella melitensis and Brucella suis has not been reported during the period of at least the preceding 42 days prior to the date of collection of the semen, oocytes or embryos; (ii) in case of animals of the family Camelidae, where all animals present have been subjected to a test for infection with Brucella abortus, Brucella melitensis and Brucella suis as referred to in Part 1 of Annex I to Delegated Regulation (EU) 2020/688 with negative results carried out on samples taken during the period of the preceding 30 days prior to the date of collection of the semen, oocytes or embryos; (f) come from an establishment where infectious bovine rhinotracheitis/infectious pustular vulvovaginitis has not been reported during the period of at least the preceding 30 days prior to the date of collection of the semen, oocytes or embryos; (g) come from an establishment where infection with epizootic haemorrhagic disease virus has not been reported during a period of at least the preceding 2 years prior to the date of collection of the semen, oocytes or embryos within a radius of 150 km around the establishment; (h) come from an establishment where infection with rabies virus has not been confirmed during the period of at least the preceding 30 days prior to the date of collection of the germinal products; (i) come from an establishment where anthrax has not been reported during the period of at least the preceding 15 days prior to the date of collection of the semen, oocytes or embryos collection; (j) come from an establishment where surra ( Trypanosoma evansi ): (i) has not been reported during a period of at least the preceding 30 days prior to the date of collection of the semen, oocytes or embryos; or (ii) has been confirmed during the preceeding 2 years, but following the last outbreak of that disease the establishment has remained under movement restrictions until: — the infected animals were removed from the establishment, and — the remaining animals on the establishment were subjected to a test for surra ( Trypanosoma evansi ) referred to in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, with negative result, carried out on samples taken at least 6 months after the infected animals were removed from the establishment; (k) fulfil animal health requirements as regards infection with bluetongue virus (serotypes 1-24) laid down in Chapter II of Part 5 of Annex II; (l) have not been in contact with animals which did not comply with the requirements set out in point (a) and in points (c) to (k) during the residency period of at least 30 days set out in point (b); (m) have been clinically examined by a veterinarian and showed no disease symptoms on the day of collection of the semen, oocytes or embryos; (n) are identified in accordance with Article 73(1) or (2) or Article 74 of Regulation (EU) 2019/2035; (o) were not used for natural breeding during a period of at least 30 days prior to the date of collection of the semen, oocytes or embryos and during the collection period.